Edgen Stock·Sep 11 2025, 19:28戻る
戻る
Ionis Pharmaceuticals Shares Rise Following Positive Olezarsen Trial Data
Edgen Stock·Sep 11 2025, 19:28
[1] Ionis Pharmaceuticals (IONS) Is Up 43.6% After Positive Phase 3 Olezarsen Results in Severe Hypertriglyceridemia – Has the Bull Case Changed? (https://finance.yahoo.com/news/ionis-pharmace ...)[2] Is The 35% Rally In IONS Stock Just The Beginning? - Forbes (https://vertexaisearch.cloud.google.com/groun ...)[3] Olezarsen and the Transformation of Severe Hypertriglyceridemia Treatment - AInvest (https://vertexaisearch.cloud.google.com/groun ...)